LUNDIRAN 250 mg Cápsulas duras
LUNDIRAN 250 mg Cápsulas duras
Commercialized
Register Number
54246
Prescription Type
Medicamento Sujeto A Prescripción Médica
Authorization Date
Jun 30, 1977
Dosage Form
CÁPSULA DURA
Route: VÍA ORAL
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number54246
EMA Approved
No
Drug Classification
✗
Generic
No
✗
Orphan
No
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (1)
NAPROXENOActive
Quantity: 250 mg
Name: NAPROXENO
ATC CLASSIFICATION (3)
M01A
M01AE
M01AE02